Table 2.
Multivariate ANOVA and GLM analysis of response time for all sessions.
| One target RT (n = 4,240 trials) | Two target RT (n = 31,849 trials) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EV | ANOVA | GLM | ANOVA | GLM | ||||||
| F | p | df | beta | p | F | p | df | beta | p | |
| Subject | 0.22 | 0.64 | 1 | 0.81 | 0.81 | 2.1 | 0.15 | 1 | 1.7 | 0.41 |
| Coh | 3.8 | **** | 14 | −40.9 | **** | 332.1 | **** | 14 | −280.2 | **** |
| Rew | 3.7 | * | 2 | −15.3 | **** | 872.8 | **** | 2 | 78.9 | **** |
| Sono | 6.6 | *** | 2 | 15.0 | *** | 11.7 | **** | 2 | −8.5 | *** |
| Drug | 11.8 | **** | 2 | * | 284.4 | **** | 2 | −37.2 | **** | |
| Coh × rew | 0.93 | 0.52 | 14 | 47.5 | **** | 14 | ||||
| Coh × sono | 1.13 | 0.32 | 14 | 2.0 | * | 14 | ||||
| Coh × drug | 1.5 | 0.12 | 14 | 7.8 | **** | 14 | ||||
| Rew × sono | 0.53 | 0.59 | 2 | 98.9 | **** | 2 | ||||
| Rew × drug | 0.86 | 0.42 | 2 | 12.7 | **** | 2 | ||||
| Sono × drug | 6.1 | ** | 2 | 34.1 | **** | 2 | ||||
Explanatory variables were subject, motion coherence (coh), offered reward (rew), sonication (sono), and haloperidol (drug). Coherence, reward, sonication and haloperidol were nested within subject
*
p < 0.05,
**
p < 0.01,
***
p < 0.001,
****
p < 0.0001.